Breath Of Health
Redefining Cancer Diagnostics
Company Overview
Snapshot
Founded in July 2020 by Ido Hadad, Breath Of Health operated with 1–10 employees. The company raised a total of $4.66 million across two funding rounds from one investor. In January 2025, Breath Of Health ceased operations.
Business overview
Breath Of Health developed a patented point-of-care system designed for the early detection of cancer and other diseases by identifying hundreds of volatile and nonvolatile organic compounds in human breath. The company's technology also included a COVID-19 test that received CE registration in Europe. Breath Of Health focused on the Health Tech & Life Sciences sector, with applications in digital healthcare, medical diagnostics, and medical devices, serving markets in Asia, the Americas, and Europe.
Strategic signal
In January 2025, Breath Of Health ceased operations. This event signals a significant challenge in the commercialization or sustained viability of its breath-based diagnostic technology, despite earlier progress in clinical studies and product development.
Log in to access full profile ›Company Intelligence Q&A
- What is Breath Of Health's primary focus?
- Breath Of Health specializes in developing a patented point-of-care system for the early detection of cancer and other diseases by analyzing volatile and nonvolatile organic compounds in human breath.
- When was Breath Of Health founded and by whom?
- Breath Of Health was founded in July 2020 by Ido Hadad.
- What was the status of Breath Of Health's operations?
- Breath Of Health ceased to operate in January 2025.
- Did Breath Of Health conduct clinical studies for its cancer detection technology?
- In April 2023, Breath Of Health announced the initiation of clinical studies for its breath-based cancer detection technology in the US, following previous studies in Israel and Europe for diagnosing various cancers.
- What was a notable early product development for Breath Of Health?
- In September 2020, Breath Of Health introduced a COVID-19 test capable of providing results in 60 seconds, which was CE registered in Europe.